PMI R&D to Revenue
Picard Medical, Inc. Common Stock · R&D to Revenue
PMI R&D to Revenue
Latest reported46.51%period ending
PMI Quarterly R&D/Revenue (0.00% → 46.51%)
Latest values, visible window
High-resolution chart · PNG
PMI r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 46.5132% | |
| 164.7826% | |
| 49.3558% | |
| 80.1179% | |
| 34.8663% | |
| 130.3226% | |
| 94.378% | |
| 109.0806% | |
| 135.4467% | |
| 34.8485% | |
| 70.2179% | |
| 0% | |
| 0% | |
| 0% |